Multiple myeloma (MM) cells can become resistant to certain drugs or combinations of drugs. Michel Delforge, MD, PhD, of the University of Leuven, Leuven, Belgium, explains that understanding the mechanisms of resistance in MM will allow for the optimization of drug choice. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.